ASB Consultores’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $263K | Buy |
+2,373
| New | +$263K | 0.18% | 104 |
|
|
2024
Q2 | – | Sell |
-4,285
| Closed | -$314K | – | 238 |
|
|
2024
Q1 | $314K | Buy |
+4,285
| New | +$314K | 0.08% | 205 |
|
|
2023
Q3 | – | Sell |
-2,992
| Closed | -$231K | – | 161 |
|
|
2023
Q2 | $231K | Buy |
2,992
+2
| +0.1% | +$154 | 0.11% | 162 |
|
|
2023
Q1 | $248K | Buy |
+2,990
| New | +$248K | 0.1% | 152 |
|
|
2022
Q3 | – | Sell |
-3,257
| Closed | -$201K | – | 186 |
|
|
2022
Q2 | $201K | Buy |
+3,257
| New | +$201K | 0.09% | 171 |
|